Bronchial asthma in children and covid-19: features of the course of сomorbidity

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4060

Full metadata record

DC Field	Value	Language
dc.contributor.author	Gulnoza Tashmatova Aloyevna, Barno Khalmatova Turdikhadjayevna.	-
dc.date.accessioned	2022-10-13T12:49:00Z	-
dc.date.available	2022-10-13T12:49:00Z	-
dc.date.issued	2022	-
dc.identifier.issn	2347-6915	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4060	-
dc.description.abstract	Bronchial asthma (BA) is one of the most common chronic lung diseases in children. At the beginning of the COVID-19 pandemic, BA, like other lung diseases, was considered a risk factor for the severe course of COVID-19.	en_US
dc.language.iso	en	en_US
dc.publisher	Other	en_US
dc.subject	Сhildren; bronchial asthma; new coronavirus infection; COVID-19; SARS-CoV-2 virus.	en_US
dc.title	Bronchial asthma in children and covid-19: features of the course of сomorbidity	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
13. Ташматова импакт фактор.pdf	Bronchial asthma in children and covid-19: features of the course of сomorbidity	113.62 kB	Adobe PDF	View/Open

DSpace JSPUI